U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 82

1.
Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma
Julie O’Neal, Feng Gao, Anjum Hassan, Ryan Monahan, Samantha Barrios, Manfred W. Kilimann, Ian Lee, Wee J. Chng, Ravi Vij, Michael H. Tomasson
Exp Hematol. Author manuscript; available in PMC 2010 May 12.
Published in final edited form as: Exp Hematol. 2009 Feb; 37(2): 234–244. doi: 10.1016/j.exphem.2008.10.014
Correction in:
volume 37 on page 532
PMCID:
PMC2868587
AbstractArticlePDF–1.2M
2.
Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH
Elie El Rassy, Alain Chebly, Rima Korban, Warde Semaan, Ziad Bakouny, Tarek Assi, Hampig Raphael Kourie, Fadi El Karak, Eliane Chouery, Joseph Kattan
Int J Hematol Oncol. 2017 Dec; 6(4): 105–111. Published online 2017 Dec 21. doi: 10.2217/ijh-2017-0019
PMCID:
PMC6172003
AbstractArticlePDF–262K
3.
Deletion (13)(q13q14.3) with retinoblastoma: confirmation and extension of a recognisable pattern of clinical features in retinoblastoma patients with 13q deletion.
T Motegi, K Ikeda, K Watanabe, Y Yanagawa, K Minoda
J Med Genet. 1987 Nov; 24(11): 696–697. doi: 10.1136/jmg.24.11.696
PMCID:
PMC1050349
SummaryPage BrowsePDF–297K
4.
Microfluidic enrichment of plasma cells improves treatment of multiple myeloma
Yunjing Zeng, Li Gao, Xiaoqing Luo, Yan Chen, Mustafa H. Kabeer, Xuelian Chen, Andres Stucky, William G. Loudon, Shengwen C. Li, Xi Zhang, Jiang F. Zhong
Mol Oncol. 2018 Jun; 12(7): 1004–1011. Published online 2018 May 12. doi: 10.1002/1878-0261.12201
Correction in:
Mol Oncol. 2021 Jan; 15(1): 317.
PMCID:
PMC6026869
AbstractArticlePDF–721K
5.
Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders
Shuhua Yi, Zengjun Li, Dehui Zou, Wenjie Xiong, Heng Li, Rui Cui, Chengwen Li, Yuting Yan, Wei Liu, Rui Lv, Zhen Yu, Weiwei Chen, Yan Xu, Gang An, Huijun Wang, Kun Ru, Tao Cheng, Jianxiang Wang, Lugui Qiu
Oncotarget. 2018 Jan 9; 9(3): 3353–3364. Published online 2017 Dec 15. doi: 10.18632/oncotarget.23261
PMCID:
PMC5790468
AbstractArticlePDF–1.4M
6.
Cytogenetic Abnormalities with Interphase FISH Method and Clinical Manifestation in Chronic Lymphocytic Leukemia Patients in North-East of Iran
Hossein Rahimi, Mohammad Hadi Sadeghian, Mohammad Reza Keramati, Amir Hossein Jafarian, Sepideh Shakeri, Seyyede Fatemeh Shams, Neda Motamedi, Maryam Sheikhi, Hossein Ayatollahi
Int J Hematol Oncol Stem Cell Res. 2017 Jul 1; 11(3): 217–224.
PMCID:
PMC5625472
AbstractArticlePDF–660K
7.
Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines
Faisal M Fadlelmola, Minglong Zhou, Ronald J de Leeuw, Nirpjit S Dosanjh, Karynn Harmer, David Huntsman, Wan L Lam, Diponkar Banerjee
Mol Cancer. 2008; 7: 2. Published online 2008 Jan 7. doi: 10.1186/1476-4598-7-2
PMCID:
PMC2254646
AbstractArticlePDF–764K
8.
MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma
Fei Li, Yan Xu, Shuhui Deng, Zengjun Li, Dehui Zou, Shuhua Yi, Weiwei Sui, Mu Hao, Lugui Qiu
Oncotarget. 2015 Nov 10; 6(35): 38270–38282. Published online 2015 Oct 12. doi: 10.18632/oncotarget.5681
PMCID:
PMC4741998
AbstractArticlePDF–1.7M
9.
Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K)
Beata Grygalewicz, Renata Woroniecka, Jolanta Rygier, Klaudia Borkowska, Iwona Rzepecka, Martyna Łukasik, Agnieszka Budziłowska, Grzegorz Rymkiewicz, Katarzyna Błachnio, Beata Nowakowska, Magdalena Bartnik, Monika Gos, Barbara Pieńkowska-Grela
Mol Cytogenet. 2016; 9: 1. Published online 2016 Jan 6. doi: 10.1186/s13039-015-0212-x
PMCID:
PMC4702365
AbstractArticlePDF–2.5M
10.
Extramedullary Manifestation in Multiple Myeloma Bears High Incidence of Poor Cytogenetic Aberration and Novel Agents Resistance
Xiaoyan Qu, Lijuan Chen, Hairong Qiu, Hua Lu, Hanxin Wu, Hongxia Qiu, Peng Liu, Rui Guo, Jianyong Li
Biomed Res Int. 2015; 2015: 787809. Published online 2015 Apr 23. doi: 10.1155/2015/787809
PMCID:
PMC4423005
AbstractArticlePDF–922K
11.
Low Serum miR-19a Expression as a Novel Poor Prognostic Indicator in Multiple Myeloma
Mu Hao, Meirong Zang, Erik Wendlandt, Yan Xu, Gang An, Dasen Gong, Fei Li, Fang Qi, Yanru Zhang, Ye Yang, Fenghuang Zhan, Lugui Qiu
Int J Cancer. Author manuscript; available in PMC 2016 Apr 15.
Published in final edited form as: Int J Cancer. 2015 Apr 15; 136(8): 1835–1844. Published online 2014 Sep 19. doi: 10.1002/ijc.29199
PMCID:
PMC4382914
AbstractArticlePDF–1.2M
12.
Plasma Cell Enrichment Enhances Detection of High-Risk Cytogenomic Abnormalities by Fluorescence In Situ Hybridization and Improves Risk Stratification of Patients With Plasma Cell Neoplasms
Gary Lu, Ramya Muddasani, Robert Z. Orlowski, Lynne V. Abruzzo, Muzaffar H. Qazilbash, M. James You, Yaping Wang, Ming Zhao, Su Chen, Isabella Claudia Glitza, L. Jeffrey Medeiros
Arch Pathol Lab Med. Author manuscript; available in PMC 2015 Mar 30.
Published in final edited form as: Arch Pathol Lab Med. 2013 May; 137(5): 625–631. doi: 10.5858/arpa.2012-0209-OA
PMCID:
PMC4378682
AbstractArticlePDF–463K
13.
Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience
Benjamin Hebraud, Florence Magrangeas, Alice Cleynen, Valerie Lauwers-Cances, Marie-Lorraine Chretien, Cyrille Hulin, Xavier Leleu, Edwige Yon, Gerald Marit, Lionel Karlin, Murielle Roussel, Anne-Marie Stoppa, Karim Belhadj, Laurent Voillat, Laurent Garderet, Margaret Macro, Denis Caillot, Mohamad Mohty, Thierry Facon, Philippe Moreau, Michel Attal, Nikhil Munshi, Jill Corre, Stephane Minvielle, Herve Avet-Loiseau
Blood. 2015 Mar 26; 125(13): 2095–2100. Prepublished online 2015 Jan 30. doi: 10.1182/blood-2014-07-587964
PMCID:
PMC4375107
AbstractArticle
14.
Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high‐risk multiple myeloma in Asian patients
Ja Min Byun, Dong‐Yeop Shin, Junshik Hong, Inho Kim, Hyun Kyung Kim, Dong Soon Lee, Youngil Koh, Sung‐Soo Yoon
Cancer Med. 2018 Mar; 7(3): 831–841. Published online 2018 Jan 29. doi: 10.1002/cam4.1340
PMCID:
PMC5852362
AbstractArticlePDF–379K
15.
Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH)
Eyad Alhourani, Martina Rincic, Moneeb AK Othman, Beate Pohle, Cordula Schlie, Anita Glaser, Thomas Liehr
Mol Cytogenet. 2014; 7: 79. Published online 2014 Nov 19. doi: 10.1186/s13039-014-0079-2
PMCID:
PMC4247644
AbstractArticlePDF–685K
16.
Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders
Ana Henriques, Arancha Rodríguez-Caballero, Ignacio Criado, Anton W. Langerak, Wendy G. Nieto, Quentin Lécrevisse, Marcos González, Emília Cortesão, Artur Paiva, Julia Almeida, Alberto Orfao
Haematologica. 2014 May; 99(5): 897–907. doi: 10.3324/haematol.2013.098913
PMCID:
PMC4008118
AbstractArticlePDF–2.3M
17.
Bcl-2 level as a biomarker for 13q14 deletion in CLL
Heba A. Degheidy, Shahinaz M. Gadalla, Mohammed Z.H. Farooqui, Fatima Abbasi, Diane C. Arthur, Steven R. Bauer, Wyndham H. Wilson, Adrian Wiestner, MA. Stetler-Stevenson, Gerald E. Marti
Cytometry B Clin Cytom. Author manuscript; available in PMC 2014 Jul 1.
Published in final edited form as: Cytometry B Clin Cytom. 2013 Jul-Aug; 84(4): 237–247. Published online 2013 May 14. doi: 10.1002/cyto.b.21090
PMCID:
PMC3963274
AbstractArticlePDF–2.5M
18.
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation
Kai Neben, Anna Jauch, Uta Bertsch, Christiane Heiss, Thomas Hielscher, Anja Seckinger, Tina Mors, Nadine Zoe Müller, Jens Hillengass, Marc S. Raab, Anthony D. Ho, Dirk Hose, Hartmut Goldschmidt
Haematologica. 2010 Jul; 95(7): 1150–1157. Published online 2010 Mar 10. doi: 10.3324/haematol.2009.016436
PMCID:
PMC2895040
AbstractArticlePDF–457K
19.
Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells
Martin Schmidt-Hieber, María Laura Gutiérrez, Martin Pérez-Andrés, Bruno Paiva, Ana Rasillo, Maria Dolores Tabernero, José Maria Sayagués, Antonio Lopez, Paloma Bárcena, María Luz Sanchez, Norma C. Gutiérrez, Jesus F. San Miguel, Alberto Orfao
Haematologica. 2013 Feb; 98(2): 279–287. doi: 10.3324/haematol.2011.060632
PMCID:
PMC3561437
AbstractArticlePDF–1.8M
20.
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961
Marilu Nelson, Sherrie L. Perkins, Bhavana J. Dave, Peter F. Coccia, Julia A. Bridge, Elizabeth R. Lyden, Nyla A. Heerema, Mark A. Lones, Lauren Harrison, Mitchell S. Cairo, Warren G. Sanger
Br J Haematol. Author manuscript; available in PMC 2011 Feb 1.
Published in final edited form as: Br J Haematol. 2010 Feb; 148(4): 600–610. Published online 2009 Nov 4. doi: 10.1111/j.1365-2141.2009.07967.x
PMCID:
PMC2921871
AbstractArticlePDF–539K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center